Since Novo's blockbuster Ozempic diabetes treatment was approved in the United States in 2017, regulators have greenlighted ...

Eli Lilly’s Kisunla Approved in China, Paving the Way for Innovative Alzheimer’s Treatment Options Elon Musk Lights Up Tesla Buzz with $690.42 Price Target and $2 Trillion Market Cap Forecast ...

From Amazon.com's workers strike to Micron's weak earnings, here's a look at some of the major developments from across the world.

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

Novo and its competitor Eli Lilly have gone to greater and greater lengths to speed their GLP-1 output, as they battle each other and the increasingly aggressive telehealth industry, which is selling ...

Ethan Slater's ex-wife, Lilly Jay, details 'sudden' divorce 'in the shadow' of Ariana Grande relationship New Earthquake Risk Areas as Taiwan's Seismic Geography Changes - TaiwanPlus News ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster ...

When individual investors are asked about investment vehicles for “innovation,” the Invesco QQQ ETF and the ARKK Innovation ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Trump tariff proposals and a more hawkish Fed add to the downside risk for gold… But we expect non-traditional factors to be ...